|
US4110368A
(en)
|
1972-07-24 |
1978-08-29 |
American Cyanamid Company |
Hydro substituted prostanoic acids and esters
|
|
US4346110A
(en)
|
1981-06-01 |
1982-08-24 |
Merrell Toraude Et Compagnie |
Method for treating depression
|
|
JPS61149964A
(ja)
|
1984-12-25 |
1986-07-08 |
Canon Inc |
電子写真感光体
|
|
US4670196A
(en)
|
1985-09-05 |
1987-06-02 |
Norton Company |
Tower packing element
|
|
ES2029799T3
(es)
|
1986-01-24 |
1992-10-01 |
Toray Industries, Inc. |
Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.
|
|
GB8827885D0
(en)
|
1988-11-30 |
1989-01-05 |
Wellcome Found |
Novel heterocyclic pesticidal compounds
|
|
US5639600A
(en)
|
1994-08-05 |
1997-06-17 |
The Regents Of The University Of California |
Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement
|
|
DE19623142A1
(de)
|
1996-06-10 |
1997-12-11 |
Huels Chemische Werke Ag |
Enantiomerenangereicherte, durch einen tertiären Kohlenwasserstoffrest substituierte Malonsäuremonoester sowie deren Herstellung
|
|
HUP9903916A3
(en)
|
1996-08-28 |
2001-06-28 |
Procter And Gamble Co Cincinna |
Phosphinic acid amides and pharmaceutical compositions containing the same
|
|
US7087648B1
(en)
|
1997-10-27 |
2006-08-08 |
The Regents Of The University Of California |
Methods for modulating macrophage proliferation using polyamine analogs
|
|
WO1999055688A1
(en)
|
1998-04-27 |
1999-11-04 |
Warner-Lambert Company |
Substituted diarylalkyl amides as calcium channel antagonists
|
|
BR9907140A
(pt)
|
1998-11-04 |
2000-10-17 |
Montell Technology Company Bv |
Componentes catalìticos sólidos, catalisadores e processo para a (co) polimerização de olefinas ch2=chr.
|
|
US6329546B1
(en)
|
1999-01-12 |
2001-12-11 |
Laboratory Of Molecular Biophotonics |
Caged amino acids
|
|
US20030203900A1
(en)
|
1999-05-18 |
2003-10-30 |
Martin Quibell |
Cysteine protease inhibitors
|
|
CZ300834B6
(cs)
|
1999-06-10 |
2009-08-19 |
Warner-Lambert Company Llc |
Mono- a disubstituované kyseliny 3-propyl-gamma-aminomáselné
|
|
KR100833371B1
(ko)
|
2001-04-27 |
2008-05-28 |
젠야쿠코교가부시키가이샤 |
헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
MXPA05001766A
(es)
|
2002-08-14 |
2005-08-19 |
Atugen Ag |
Uso de proteina quinasa n beta.
|
|
US6787664B2
(en)
|
2002-09-17 |
2004-09-07 |
Warner-Lambert Company Llc |
Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogs
|
|
AU2002953255A0
(en)
|
2002-12-11 |
2003-01-02 |
Cytopia Research Pty Ltd |
Protein kinase inhibitors
|
|
WO2004089925A1
(en)
|
2003-04-03 |
2004-10-21 |
Semafore Pharmaceuticals, Inc. |
Pi-3 kinase inhibitor prodrugs
|
|
ES2382377T3
(es)
|
2003-05-30 |
2012-06-07 |
Gemin X Pharmaceuticals Canada Inc. |
Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
|
|
WO2005007623A2
(en)
|
2003-07-03 |
2005-01-27 |
The Trustees Of The University Of Pennsylvania |
Inhibition of syk kinase expression
|
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
|
US20070212428A1
(en)
|
2004-06-04 |
2007-09-13 |
Mood Management Sciences, Inc. |
Methods and compositions for treating mood disorder
|
|
DE102004053407A1
(de)
|
2004-11-05 |
2006-05-11 |
Bayer Healthcare Ag |
Acylierte Nonadepsipeptide II
|
|
US7449458B2
(en)
|
2005-01-19 |
2008-11-11 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
MX2007009985A
(es)
|
2005-02-18 |
2008-03-11 |
Innodia Inc |
Diastereoisomeros de 4-hidroxiisoleucina y usos de los mismos.
|
|
ES2493466T3
(es)
|
2005-05-12 |
2014-09-11 |
Abbvie Bahamas Ltd. |
Promotores de la apoptosis
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
US7402325B2
(en)
|
2005-07-28 |
2008-07-22 |
Phoenix Biotechnology, Inc. |
Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
|
|
HRP20140975T1
(hr)
|
2005-10-07 |
2014-11-21 |
Exelixis, Inc. |
Derivati n-(3-amino-hinoksalin-2-il)-sulfonamida i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze
|
|
WO2007053452A1
(en)
|
2005-11-01 |
2007-05-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
KR101533461B1
(ko)
|
2006-04-26 |
2015-07-02 |
에프. 호프만-라 로슈 아게 |
Pi3k저해제로 유용한 티에노[3,2-d]피리미딘 유도체
|
|
CN101573334A
(zh)
|
2006-08-21 |
2009-11-04 |
普雷萨药品公司 |
用于治疗中枢神经系统障碍的多介质转运体抑制剂
|
|
EP2529621B1
(en)
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
EP2069339B1
(en)
|
2006-09-25 |
2011-05-18 |
Wockhardt Research Centre |
Substituted piperidinophenyl oxazolidinones
|
|
TWI397418B
(zh)
|
2006-10-10 |
2013-06-01 |
Otsuka Pharma Co Ltd |
抗憂鬱劑
|
|
RU2009118935A
(ru)
|
2006-10-20 |
2010-11-27 |
Мерк энд Ко., Инк. (US) |
Земещенные имидазолы в качестве модуляторов подтипа 3 бомбезиновых рецепторов
|
|
HUE029188T2
(en)
|
2007-03-12 |
2017-03-28 |
Ym Biosciences Australia Pty |
Phenylamino-pyrimidine compounds and their use
|
|
US8394794B2
(en)
|
2007-03-23 |
2013-03-12 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
US8431608B2
(en)
|
2007-08-17 |
2013-04-30 |
Icagen Inc. |
Heterocycles as potassium channel modulators
|
|
US8445686B2
(en)
|
2007-08-27 |
2013-05-21 |
Abbvie Inc. |
4-(4-pyridinyl)-benzamides and their use as rock activity modulators
|
|
MY165582A
(en)
|
2008-03-11 |
2018-04-05 |
Incyte Holdings Corp |
Azetidine and cyclobutane derivatives as jak inhibitors
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
WO2010044885A2
(en)
|
2008-10-17 |
2010-04-22 |
Whitehead Institute For Biomedical Research |
Soluble mtor complexes and modulators thereof
|
|
JP2012530116A
(ja)
|
2009-06-19 |
2012-11-29 |
レツク・フアーマシユーテイカルズ・デー・デー |
脱ハロゲン化なしにハロゲノアルケンを水素化する方法
|
|
US20120219596A1
(en)
|
2009-07-30 |
2012-08-30 |
Wendelin Stark |
Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
|
|
CA2786245A1
(en)
|
2010-01-29 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and their use as syk kinase inhibitors
|
|
JP5744021B2
(ja)
|
2010-06-30 |
2015-07-01 |
富士フイルム株式会社 |
新規なニコチンアミド誘導体またはその塩
|
|
CN102464701B
(zh)
|
2010-11-08 |
2015-10-21 |
上海医药工业研究院 |
一类新型化合物、其制备方法及用途
|
|
WO2012076063A1
(en)
|
2010-12-10 |
2012-06-14 |
Rottapharm S.P.A. |
Pyridine amide derivatives as ep4 receptor antagonists
|
|
EP2678037B1
(en)
|
2011-02-25 |
2014-12-03 |
Lonza Ltd |
Branched linker for protein drug conjugates
|
|
US9321727B2
(en)
|
2011-06-10 |
2016-04-26 |
Hoffmann-La Roche Inc. |
Pyridine derivatives as agonists of the CB2 receptor
|
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
EP2589383A1
(en)
|
2011-11-06 |
2013-05-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin |
FKBP subtype-specific rapamycin analogue for use in treatment of diseases
|
|
WO2013142229A1
(en)
|
2012-03-19 |
2013-09-26 |
President And Fellows Of Harvard College |
Designing novel peptides for inducing fibronectin matrix assembly
|
|
EP3202397B1
(en)
|
2012-08-06 |
2019-09-25 |
Pitney Pharmaceuticals Pty Limited |
Compounds for the treatment of mtor pathway related diseases
|
|
US20160002159A1
(en)
|
2013-02-13 |
2016-01-07 |
Neal ZONDLO |
Perfluoro-tert-butyl hydroxyproline
|
|
WO2014145852A2
(en)
|
2013-03-15 |
2014-09-18 |
Knopp Biosciences Llc |
Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
|
|
WO2014201111A1
(en)
|
2013-06-14 |
2014-12-18 |
The Brigham And Women's Hospital, Inc. |
Treatment of mtor hyperactive related diseases and disorders
|
|
US10168338B2
(en)
|
2014-09-12 |
2019-01-01 |
Whitehead Institute For Biomedical Research |
Methods of identifying modulators of sestrin-gator-2 interaction for modulating mTORC1 activity
|
|
MX389001B
(es)
*
|
2015-10-23 |
2025-03-20 |
Navitor Pharm Inc |
Moduladores de interacción de sestrina-gator2 y sus usos.
|
|
WO2017083823A1
(en)
|
2015-11-13 |
2017-05-18 |
Brandeis University |
Mtor inhibitors and methods of use thereof
|
|
US10512656B2
(en)
|
2016-04-21 |
2019-12-24 |
Baylor College Of Medicine |
Compositions and methods for the treatment of lysosomal storage disorders and disorders characterized by lysosomal dysfunction
|
|
ES3040534T3
(en)
*
|
2017-04-26 |
2025-11-03 |
Navitor Pharm Inc |
Modulator of sestrin-gator2 interaction for use in the treatment of treatment-resistant depression
|
|
US10653652B2
(en)
|
2018-02-08 |
2020-05-19 |
Ovid Therapeutics Inc. |
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
|
|
WO2020086816A1
(en)
|
2018-10-24 |
2020-04-30 |
Navitor Pharmaceuticals, Inc. |
Polymorphic compounds and uses thereof
|
|
US10926803B2
(en)
|
2019-07-17 |
2021-02-23 |
GM Global Technology Operations LLC |
Four rail front crush structure with load dissemination into eight element support structure
|
|
AU2020376950B2
(en)
|
2019-11-01 |
2026-06-11 |
Supernus Pharmaceuticals, Inc. |
Methods of treatment using an mTORC1 modulator
|
|
JP6689441B1
(ja)
|
2019-11-01 |
2020-04-28 |
エヌ・ティ・ティ・コミュニケーションズ株式会社 |
電子マネー管理システムおよび電子マネー管理方法
|